And a sixth! After AstraZeneca, Sanofi-GSK, Johnson&Johnson, Curevac, and Moderna, the European Commission will now secure a stockpile of Covid-19 vaccines from BioNTech-Pfizer. The institution announced on Wednesday 9 September, that it had concluded preliminary discussions with this German-American alliance.
BioNTech-Pfizer
As indicated (see EUROPE B12552A17), contacts between the EU and BioNTech-Pfizer had been ongoing for several weeks. At this stage, the Commission foresees an...